Searched for
MANDIDEEP FACILITY
Textile sector: Time for a relook as tariff tantrum may soon be history? 5 textile stocks with upside potential of up to 27%The Indian textile and apparel sector has had a stressful year. The US tariffs disrupted orders to the sector’s largest market, squeezed ma...- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- USFDA issues Form-483 with 8 observations to Lupin's drug, API production facilities in Mandideep plantThe USFDA had inspected the Mandideep Unit-1 facility in Madhya Pradesh from November 14, 2022, to November 23, 2022, the Mumbai-based drug...
- HEG to become world's largest graphite manufacturing unit by end of this year: Chairman Ravi JhunjhunwalaIn the second phase, new investment is being made by the unit in the state for manufacturing graphite anodes. In view of the increasing dem...
- USFDA red flags Lupin for significant violations at MP unitThe USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.
- Lupin gets warning letter from USFDA for Mandideep facilityShares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE.
- Reduce Lupin, target Rs 840: Kotak Institutional EquitiesReduce Lupin at a price target of Rs 840.
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...
- Normalcy in operations to be restored soon: Crompton GreavesThe company had earlier announced that it has halted operations at its manufacturing unit at Mandideep in Madhya Pradesh after it was hit b...
- Lupin recalls over 54K vials of anti-bacterial injection in USThe ongoing voluntary recall is a class III recall and is for the US and Puerto Rico, according to the latest enforcement report on USFDA s...
- Lupin terms USFDA observations "minor", brokerages say nothing to worry aboutThe company received three observations relating to violation of production norms at manufacturing facilities at Mandideep, Madhya Pradesh ...
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.
- Drug major Lupin receives ISRS certificationDrug major Lupin Ltd today said the company has received certification for International Sustainability Rating Standard, 8th edition (ISRS)...
- Lupin gets US FDA nod for anti-depressantDrug maker Lupin has received US Food and Drug Association (FDA) approval for anti-depressant, it said on Wednesday.
- Lupin plants get USFDA nod; co to sell new productsDrug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...
- Citi maintains 'buy' on LupinCiti has maintained its 'buy' rating on mid-sized Indian pharma firm Lupin, and raised its target price to Rs 1,415, following the acquisit...
- FDA observations not to affect supply: LupinDrug major Lupin on Friday said supply of products manufactured at its Mandideep facility will not be affected despite the US Food and Drug...
- Lupin’s MP plant under USFDA scannerThe US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...
Load More
